Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Afatinib Plus Nimotuzumb for NSCLC

Phase 1

Conditions: NSCLC

Interventions: Drug: afatinib (30 or 40mg) + nimotuzumab (100 or 200mg)

First Posted Date: 2013-05-23

Last Posted Date: 2014-02-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 50

Registration Number: NCT01861223

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer

Phase 2

Conditions: Squamous NSCLC

Interventions: Drug: Dovitinib

First Posted Date: 2013-05-23

Last Posted Date: 2013-05-23

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 27

Registration Number: NCT01861197

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach

Completed

Conditions: Aortic Surgery
Postoperative Acute Kidney Injury

Interventions: Procedure: elective or emergency aortic surgery (including ascending, arch, descending thoracic aorta)

First Posted Date: 2013-05-01

Last Posted Date: 2013-12-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 375

Registration Number: NCT01844219

Locations: 🇰🇷
Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea, Republic of

Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer

Recruiting

Conditions: Sarcoma

First Posted Date: 2013-04-15

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1000

Registration Number: NCT01831609

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Spine Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord Compression

Phase 2

Conditions: Spinal Cord Compression

Interventions: Radiation: Stereotactic body radiation therapy

First Posted Date: 2013-04-08

Last Posted Date: 2014-12-02

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 43

Registration Number: NCT01826058

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Vandetanib in Advanced NSCLC With RET Rearrangement

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Vandetanib

First Posted Date: 2013-04-04

Last Posted Date: 2020-12-07

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 17

Registration Number: NCT01823068

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Kidney Graft Function Under the Immunosuppression Strategies

Phase 4

Completed

Conditions: Chronic Renal Disease

Interventions: Drug: Standard Dose of Myfortic and Reduced Dose of Myfortic
Drug: Prednisolone OR methylprednisolone OR deflazacort injected both control group and experimental group
Drug: Basiliximab injected both control group and experimental group

First Posted Date: 2013-03-25

Last Posted Date: 2014-10-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 140

Registration Number: NCT01817322

The Concomitant Cryomaze Procedure Using Nitreous Oxide Cryoprobe: Comparison With Argon Based Cryoprobe

Not Applicable

Completed

Conditions: Valve
Atrial Fibrillation

Interventions: Device: Cryomaze procedure using Argon
Device: Cryomaze procedure using Nitrous oxide

First Posted Date: 2013-03-18

Last Posted Date: 2017-08-24

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 60

Registration Number: NCT01812356

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Phase IV Study to Evaluate the Efficacy and Safety of Mircera in PD

Phase 4

Conditions: PD

Interventions: Drug: Mircera

First Posted Date: 2013-03-08

Last Posted Date: 2013-06-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 101

Registration Number: NCT01807481

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

Phase 2

Conditions: Neuroblastoma
Soft Tissue Sarcoma
Ewing Sarcoma
Rhabdomyosarcoma
Osteosarcoma

Interventions: Procedure: haploidentical stem cell transplantation and NK cell therapy

First Posted Date: 2013-03-08

Last Posted Date: 2018-09-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 12

Registration Number: NCT01807468

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy